Dr. Lindsey Watford, FNP
What this data tells you about Dr. Watford
Dr. Lindsey Watford is a nurse practitioner - family in Venice, FL, with 6 years in practice. Based on federal Medicare data, Dr. Watford performed 3,566 Medicare services across 1,594 unique beneficiaries.
Between the years covered by Open Payments, Dr. Watford received a total of $24,947 from 31 pharmaceutical and/or device companies across 293 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Watford is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 | 1,238 | $4 | $13 |
| Amnioarmor, per square centimeter | 406 | $791 | $1,520 |
| Destruction of precancerous skin growth, 1 | 329 | $32 | $129 |
| Office visit, established patient (20-29 min) | 303 | $55 | $175 |
| Biopsy of related skin growth, each additional growth | 223 | $31 | $97 |
| Office visit, established patient (10-19 min) | 191 | $34 | $109 |
| Skin biopsy, tangential | 184 | $58 | $195 |
| Destruction of skin growths (warts/lesions), 1-14 | 155 | $68 | $170 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 109 | $298 | $875 |
| Application of light by qualified health care professional to destroy precancer skin growth | 81 | $151 | $431 |
| Destruction of precancer skin growth, 15 or more growths | 57 | $106 | $326 |
| New patient office visit (30-44 min) | 52 | $63 | $219 |
| Office visit, established patient (30-39 min) | 50 | $77 | $248 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 48 | $108 | $308 |
| Removal of skin tag, 1-15 skin tags | 24 | $40 | $177 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 21 | $102 | $474 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | 20 | $56 | $194 |
| New patient office or other outpatient visit, 15-29 minutes | 20 | $33 | $140 |
| Biopsy of ear | 18 | $36 | $187 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 13 | $86 | $285 |
| Acne surgery | 12 | $69 | $224 |
| Application of light to destroy precancer skin growth | 12 | $91 | $262 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (74%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for nurse practitioner - family in FL.
Geographic Context
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Watford is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (consulting-driven, top 0%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Watford experienced with destruction of precancerous skin growths, 2-14?
Does Dr. Watford receive payments from pharmaceutical companies?
How do Dr. Watford's costs compare to other nurse practitioner - familys in Venice?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology